Rentokil reports strong Q3 results, driven by North America's pest control and business services growth, as well as strategic acquisitions and portfolio reshaping.
BridgeBio reports positive Phase 3 results for two late-stage candidates, encaleret and BBP-418, driving a sharp rally in the company's shares.
Rentokil reports strong Q3 results, driven by North America's pest control and business services growth, as well as strategic acquisitions and portfolio reshaping.
BridgeBio reports positive Phase 3 results for two late-stage candidates, encaleret and BBP-418, driving a sharp rally in the company's shares.